Ledger.Open graph →

SEC Form D · Amendment · filed December 5, 2016

NEXEON MEDSYSTEMS INC

Offering

$5.5M

Sold

$4.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

LEXINGTON, KY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

William M. Rosellini · LEXINGTON, KYExec · Director Ronald M. Conquest · LEXINGTON, KYExec · Director Mark C. Bates · LEXINGTON, KYDirector Jay S. Lucas · New York, NYDirector George D. Doney · Riva, MDExec · Director John C. Hensel · Riva, MDExec · Director Research Boston Management · Boston, MAExec · Director Mir M. Ahmad, M.D · Hazlet, NJExec · Director Maureen M. Marshall · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗